مقاله‌های دارای تعهدات انتشار عمومی - Sooryanarayana Varambally, Ph.D., MBAبیشتر بدانید
جای دیگری دردسترس نیست: ۳
مرور
Wnt receptor Frizzled 8 is a target of ERG in prostate cancer‏
BVSK Chakravarthi, DS Chandrashekar, SA Hodigere Balasubramanya, ...‏
The Prostate 78 (16), 1311-1320, 2018‏
تعهدات: US National Institutes of Health‏
مرور
Systemic anti-inflammatory therapy aided by curcumin-laden double-headed nanoparticles combined with injectable long-acting insulin in a rodent model of diabetes eye disease‏
R Ganugula, M Arora, S Dwivedi, DS Chandrashekar, S Varambally, ...‏
ACS nano 17 (7), 6857-6874, 2023‏
تعهدات: US National Institutes of Health‏
مرور
Prostate cancer: an update on molecular pathology with clinical implications‏
GJ Netto, ML Eich, S Varambally‏
European Urology Supplements 16 (12), 253-271, 2017‏
تعهدات: US National Institutes of Health‏
جای دیگری دردسترس است: ۹۸
مرور
UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses‏
DS Chandrashekar, B Bashel, SAH Balasubramanya, CJ Creighton, ...‏
Neoplasia 19 (8), 649-658, 2017‏
تعهدات: US National Institutes of Health‏
مرور
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression‏
A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ...‏
Nature 457 (7231), 910-914, 2009‏
تعهدات: US National Institutes of Health‏
مرور
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer‏
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...‏
Nature medicine 22 (3), 298-305, 2016‏
تعهدات: US National Institutes of Health, European Commission, Damon Runyon Cancer …‏
مرور
UALCAN: An update to the integrated cancer data analysis platform‏
DS Chandrashekar, SK Karthikeyan, PK Korla, H Patel, AR Shovon, ...‏
Neoplasia 25, 18-27, 2022‏
تعهدات: US Department of Defense, US National Institutes of Health‏
مرور
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer‏
S Varambally, Q Cao, RS Mani, S Shankar, X Wang, B Ateeq, B Laxman, ...‏
science 322 (5908), 1695-1699, 2008‏
تعهدات: US National Institutes of Health‏
مرور
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression‏
J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ...‏
Cancer cell 17 (5), 443-454, 2010‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute‏
مرور
Repression of E-cadherin by the polycomb group protein EZH2 in cancer‏
Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ...‏
Oncogene 27 (58), 7274-7284, 2008‏
تعهدات: US National Institutes of Health‏
مرور
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma‏
N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ...‏
Nature medicine 16 (7), 793-798, 2010‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …‏
مرور
Mechanistic rationale for inhibition of poly (ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer‏
JC Brenner, B Ateeq, Y Li, AK Yocum, Q Cao, IA Asangani, S Patel, ...‏
Cancer cell 19 (5), 664-678, 2011‏
تعهدات: US National Institutes of Health‏
مرور
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers‏
F Chen, DS Chandrashekar, S Varambally, CJ Creighton‏
Nature communications 10 (1), 5679, 2019‏
تعهدات: US National Institutes of Health‏
مرور
Induced chromosomal proximity and gene fusions in prostate cancer‏
RS Mani, SA Tomlins, K Callahan, A Ghosh, MK Nyati, S Varambally, ...‏
Science 326 (5957), 1230-1230, 2009‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute‏
مرور
Antibody-based detection of ERG rearrangement-positive prostate cancer‏
K Park, SA Tomlins, KM Mudaliar, YL Chiu, R Esgueva, R Mehra, ...‏
Neoplasia 12 (7), 590-IN21, 2010‏
تعهدات: US National Institutes of Health‏
مرور
The role of SPINK1 in ETS rearrangement-negative prostate cancers‏
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...‏
Cancer cell 13 (6), 519-528, 2008‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute‏
مرور
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction‏
E Zhao, T Maj, I Kryczek, W Li, K Wu, L Zhao, S Wei, J Crespo, S Wan, ...‏
Nature immunology 17 (1), 95-103, 2016‏
تعهدات: US National Institutes of Health‏
مرور
Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior‏
SK Bandari, A Purushothaman, VC Ramani, GJ Brinkley, ...‏
Matrix Biology 65, 104-118, 2018‏
تعهدات: US National Science Foundation, US National Institutes of Health‏
مرور
Coordinated regulation of polycomb group complexes through microRNAs in cancer‏
Q Cao, RS Mani, B Ateeq, SM Dhanasekaran, IA Asangani, JR Prensner, ...‏
Cancer cell 20 (2), 187-199, 2011‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute‏
مرور
Genomic and epigenomic alterations in cancer‏
BVSK Chakravarthi, S Nepal, S Varambally‏
The American journal of pathology 186 (7), 1724-1735, 2016‏
تعهدات: US National Institutes of Health‏
اطلاعات انتشارات و تأمین بودجه به‌طورخودکار توسط برنامه رایانه‌ای تعیین می‌شود.